Literature DB >> 8598455

The role of NK cells during in vivo antigen-specific antibody responses.

J A Wilder1, C Y Koh, D Yuan.   

Abstract

Investigations into the role of NK cells in regulating Ab responses have yielded variable results, some suggesting that NK cells can down-regulate Ag-specific Ig production and others proposing an enhancing effect. These apparently inconsistent findings may stem partially from the specificity of reagents used in purifying cell populations and/or the nature of the in vitro systems used to study these events. We chose to investigate the ability of either resting or poly(I:C)-activated NK cells to alter an in vivo Ab response in mice given a T-independent (TNP-LPS) or T-dependent (TNP-keyhole limpet hemocyanin (KLH)) Ag. By using a more specific Ab, anti-NK-1.1, to deplete NK cells, we were able to clearly show that resting, endogenous NK cells do not affect either type of response, as measured by serum Ag-specific Ig levels quantitated by isotype-specific ELISA. In contrast, activation of NK cells by poly(I:C) increased Ag-specific IgC2a as well as IgG1 levels. Interestingly, only the effect on IgG2a production is reversible by depletion of NK cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598455

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.

Authors:  Defu Zeng; Yinping Liu; Stephane Sidobre; Mitchell Kronenberg; Samuel Strober
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.

Authors:  Suwan Sinha; Yuhong Guo; Suwannee Thet; Dorothy Yuan
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

Review 3.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

4.  Enhancement of antigen-specific immunoglobulin G responses by anti-CD48.

Authors:  Dorothy Yuan; Yuhong Guo; Suwannee Thet
Journal:  J Innate Immun       Date:  2012-11-27       Impact factor: 7.349

5.  Up-regulation of CD40 ligand and induction of a Th2 response in children immunized with pneumococcal polysaccharide vaccines.

Authors:  L E Leiva; B Butler; J Hempe; A P Ortigas; R U Sorensen
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.

Authors:  M L Mbow; N Zeidner; R D Gilmore; M Dolan; J Piesman; R G Titus
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis.

Authors:  Kalle Söderström; Emily Stein; Paula Colmenero; Ulrich Purath; Ulf Müller-Ladner; Cristina Teixeira de Matos; Ingo H Tarner; William H Robinson; Edgar G Engleman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 8.  Natural Killer Cell Regulation of B Cell Responses in the Context of Viral Infection.

Authors:  Ivayla E Gyurova; Ayad Ali; Stephen N Waggoner
Journal:  Viral Immunol       Date:  2019-12-03       Impact factor: 2.257

9.  Characterization of an immunomodulatory Der p 2-FIP-fve fusion protein produced in transformed rice suspension cell culture.

Authors:  Chin-Fen Su; I-Chun Kuo; Peng-Wen Chen; Chiung-Hui Huang; See Voon Seow; Kaw Yan Chua; Su-May Yu
Journal:  Transgenic Res       Date:  2011-05-10       Impact factor: 2.788

10.  Antigen-specific responses and ANA production in B6.Sle1b mice: a role for SAP.

Authors:  Paula Jennings; Alice Chan; Pamela Schwartzberg; Edward K Wakeland; Dorothy Yuan
Journal:  J Autoimmun       Date:  2008-10-08       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.